A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus

Acta Virologica

Volumn 47, Issue 4, 2003, Pages 229-236

  Vareckova E ^a   Wharton, S A ^b   Mucha, V ^a   Gocnik M ^a   Kostolansky F ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Fusion; HA2 glycoprotein; Hemagglutinin; Influenza A virus; Monoclonal antibody; Virus neutralization

Indexed keywords

AMANTADINE; EPITOPE; HA1 GLYCOPROTEIN; HA2 GLYCOPROTEIN; HYBRID PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CF2; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENE MUTATION; INFLUENZA VIRUS A; MOUSE; MUTANT; NONHUMAN; PH; RADIOIMMUNOASSAY; VIRUS CULTURE; VIRUS INHIBITION; VIRUS RESISTANCE; WILD TYPE;

AMANTADINE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS; MEMBRANE FUSION; MICE; MUTATION; PLAQUE ASSAY; PROTEIN CONFORMATION; VIRAL FUSION PROTEINS; VIRUS REPLICATION;

ANIMALIA; INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0442294070     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Becht H, Huang RTC, Fleischer B, Boschek CB, Rott R (1984): Immunogenic properties of the small chain HA2 of the haemagglutinin of influenza viruses. J. Gen. Virol. 65, 173-183.
2. Brand CM, Skehel JJ (1972): Crystalline antigen from the influenza virus envelope. Nat. New. Biol. 238, 145.
3. Cox RJ, Brokstadt KA (1999): The postvaccination antibody response to influenza virus proteins. Acta Pathol. Microbiol. Immunol. Scand. 107, 289-196.
4. Daniels RS, Douglas AR, Skehel JJ, Wiley DC (1983): Analysis of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J. Gen. Virol. 64, 1657-1662.
5. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, Wang ML, Wiley DC (1985): Fusion mutants of the influenza virus haemagglutinin glycoprotein. Cell 40, 431-439.
6. Ey PL, Prowse SJ, Jenkin CR (1978): Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using Protein A-Sepharose. Biochemistry 15, 429-436.
7. Edwards MJ, Dimmock NJ (2000): Two influenza A virus-specific FAbs neutralize by inhibiting virus attachments to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition. Virology 278, 423-435.
8. Edwards MJ, Dimmock NJ (2001): A haemagglutinin (HA1)-specific Fab neutralizes influenza A virus by inhibiting fusion activity. J. Gen. Virol. 82, 1387-1395.
9. Gerhard W (2001): The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol. 260, 171-190.
10. Graves PN, Schulman JL, Young JF, Palese P (1983): Preparation of influenza virus subviral particles lacking the HA1 subunit of haemagglutinin: unmasking of cross-reactive HA2 determinants. Virology 126, 106-116.
11. Hunter WM (1967): The preparation of radioiodinated proteins of high avidity, their reaction with antibody in vitro. In Weir DM (Ed.): Handbook of Experimental Immunology. Blackwell Scientific Publication, Oxford, pp. 608-612.
12. Imai M, Sugimoto K, Okazaki K, Kida H (1998): Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin. Virus Res. 53, 129-139.
13. Ivanova VT, Yakhno MA, Soláriková L, Stumpa A, Varečková E, Slepushkin AN (1991): Study of antigenic and biological properties of influenza A (H1N1) viruses in the USSR and CzFSR, 1988-1989. Vopr. Virusol. 36, 378-380.
14. Kida H, Yoden S, Kuwabara M, Yanagawa R (1985): Interference with a conformational change in the HA molecule of influenza virus by antibodies as a possible neutralization mechanism. Vaccine 3, 219-222.
15. Kostolanský F, Russ G, Mucha V, Styk B (1988): Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2. Arch. Virol. 101, 13-24.
16. Kostolanský F, Styk B, Russ G (1989): Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2. Acta Virol. 33, 504-512.
17. Kostolanský F, Mucha V, Betáková T, Varečková E (1994): Antibody response to hidden epitope of influenza A haemagglutinin elicited by anti-idiotypic antibodies. Acta. Virol. 38, 215-222.
18. Kostolanský F, Varečková E, Betáková T, Mucha V, Russ G, Wharton SA (2000): The strong positive correlation between effective affinity and infectivity neutralization of highly cross-reactive monoclonal antibody IIB4, which recognizes antigenic site B on influenza A virus haemagglutinin. J. Gen. Virol. 81, 1727-1735.
19. Kostolanský F, Mucha V, Slováková R, Varečková E (2002): Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide. Acta Virol. 46, 229-236.
20. Nobusawa E, Aoyama T, Kato H, Suzuki Y, Tateno Y, Nakajima K (1991): Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182, 475-485.
21. Okuno Y, Isegawa Y, Sasao F, Ueda S (1993): A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67, 2552-2558.
22. Russ G, Varečková E, Styk B (1974): Steric effects in the reaction of influenza virus neuraminidase with antibodies. Acta Virol. 18, 299-306.
23. Russ G, Styk B, Poláková K (1978): Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. II. Reactivity with rabbit sera against intact virus and purified undissociated haemagglutinin. Acta Virol. 31, 374-386.
24. Russ G, Poláková K, Kostolanský F, Styk B, Vančíková M (1987): Monoclonal antibodies to glycopeptides HA1 and HA2 of influenza virus hemagglutinin. Acta Virol. 31, 374-386.
25. Sánchez-Fauquier A, Villanueva N, Melero JA (1987): Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits. Arch. Virol. 97, 251-65.
26. Skehel JJ, Wiley DC (2000): Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569.
27. Styk B, Russ G, Poláková K (1979): Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera. Acta Virol. 23, 1-8.
28. Vanlandschoot P, Beirnaert ER, Barrere B, Calder L, Millar B, Wharton S, Min Jou W, Fiers W (1998): An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus. J. Gen. Virol. 79, 1781-1791.
29. Varečková E, Mucha V, Čiampor F, Betáková T, Russ G (1993): Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules. Arch. Virol. 130, 45-56.
30. Varečková E, Betáková T, Mucha V, Soláriková L, Kostolanský F, Waris M, Russ G (1995): Preparation of monoclonal antibodies for the diagnosis of influenza A infection using different immunisation protocols. J. Immunol. Methods 180, 107-116.
31. Varečková E, Cox N, Klimov A (2002): Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins. J. Clin. Microbiol. 40, 2220-2223.
32. Varečková E, Mucha V, Wharton SA, Kostolanský F (2003): Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies. Arch. Virol. 148, 469-486.
33. Wharton SA, Skehel JJ, Wiley DC (1986):. Studies of influenza haemagglutinin-mediated membrane fusion. Virology 149, 27-35.
34. Yewdell JW, Taylor A, Yellen A, Caton A, Gerhard W, Bächi T (1993): Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region. J. Virol. 67, 933-942.